CD4 and breast carcinoma: We could show that CD4+ T-cells obtained from patients with breast cancer exhibit a reduced responsiveness to IL-7, defined by statistically reduced STAT-5 phosphorylation; these data suggested that differences in IL-7R expression, on the single cell level, may indeed translate into biologically relevant responses to IL-7 [27].